Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Progress in Neurobiology

Volumn 142, Issue , 2016, Pages 45-67

  Kline, Anthony E ^a,b,c   Leary, Jacob B ^a,b,d   Radabaugh, Hannah L ^a,b   Cheng, Jeffrey P ^a,b   Bondi, Corina O ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cognition; Combination therapies; Controlled cortical impact; Environmental enrichment; Fluid percussion; Neurobehavioral; Stem cells; Traumatic brain injury

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ACETYLCYSTEINE; ASCORBIC ACID; AZETIRELIN; BOTULINUM TOXIN; BUSPIRONE; CITICOLINE; CURCUMIN; DEXAMETHASONE; DEXTRORPHAN; DIZOCILPINE MALEATE; DOCOSAHEXAENOIC ACID; FENOFIBRATE; INTERLEUKIN 10; KETAMINE; LITHIUM; MAGNESIUM CHLORIDE; MAGNESIUM SULFATE; MELATONIN; METHYLPHENIDATE; MINOCYCLINE; N ACETYLTRYPTOPHAN; NALMEFENE; NICOTINAMIDE; PROGESTERONE; RIBOFLAVIN; SIMVASTATIN; SUBSTANCE P; UNINDEXED DRUG; VALPROIC ACID; NEUROPROTECTIVE AGENT;

COGNITION; COMBINATION CHEMOTHERAPY; CONVALESCENCE; EMBRYONIC STEM CELL; ENVIRONMENTAL ENRICHMENT; EXERCISE; EXPERIMENTAL TRAUMATIC BRAIN INJURY; HUMAN; INDUCED HYPOTHERMIA; INFLAMMATION; INVOLUNTARY MOVEMENT; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REHABILITATION CARE; REVIEW; STEM CELL; STROMA CELL; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES, TRAUMATIC; COGNITIVE THERAPY; METABOLISM; MULTIMODALITY CANCER THERAPY; PROCEDURES; PSYCHOLOGY; STEM CELL TRANSPLANTATION;

ANIMALS; BRAIN INJURIES, TRAUMATIC; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; HUMANS; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION;

EID: 84969959978     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2016.05.002     Document Type: Review

References (286)

1. Abdel Baki S.G., Schwab B., Haber M., Fenton A.A., Bergold P.J. Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats. PLoS One 2010, 5:e12490.
2. Acosta S.A., Tajiri N., Shinozuka K., Ishikawa H., Sanberg P.R., Sanchez-Ramos J., Song S., Kaneko Y., Borlongan C.V. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PLoS One 2014, 9:e90953.
3. Acosta S.A., Tajiri N., de la Pena I., Bastawrous M., Sanberg P.R., Kaneko Y., Borlongan C.V. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease. J. Cell Physiol. 2015, 230:1024-1032.
4. Agoston D.V. Bench-to-bedside and bedside back to the bench; seeking a better understanding of the acute pathophysiological process in severe traumatic brain injury. Front. Neurol. 2015, 6:47.
5. Agrawal R., Noble E., Tyagi E., Zhuang Y., Ying Z., Gomez-Pinilla F. Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation. Biochim. Biophys. Acta 2015, 1852:862-872.
6. Albrecht J.S., Hirshon J.M., McCunn M., Bechtold K.T., Rao V., Simoni-Wastila L., Smith G.S. Increased rates of mild traumatic brain injury among older adults in US emergency departments, 2009-2010. J. Head Trauma Rehabil. 2015, (Epub ahead of print).
7. Algattas H., Huang J.H. Traumatic brain injury pathophysiology and treatments: early, intermediate, and late phases post-injury. Int. J. Mol. Sci. 2013, 15:309-341.
8. Allyson J., Bi X., Baudry M., Massicotte G. Maintenance of synaptic stability requires calcium-independent phospholipase A2 activity. Neural Plast. 2012, 2012:569149.
9. Alway Y., Gould K.R., Johnston L., McKenzie D., Ponsford J. A prospective examination of Axis I psychiatric disorders in the first 5 years following moderate to severe traumatic brain injury. Psychol. Med. 2016, 46:1331-1341.
10. Anthonymuthu T.S., Kenny E.M., Bayir H. Therapies targeting lipid peroxidation in traumatic brain injury. Brain Res. 2016, 1640:57-576.
11. Bales J.W., Wagner A.K., Kline A.E., Dixon C.E. Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis. Neurosci. Biobehav. Rev. 2009, 33:981-1003.
12. Baranova A.I., Whiting M.D., Hamm R.J. Delayed, post-injury treatment with aniracetam improves cognitive performance after traumatic brain injury in rats. J. Neurotrauma 2006, 23:1233-1240.
13. Barbre A.B., Hoane M.R. Magnesium and riboflavin combination therapy following cortical contusion injury in the rat. Brain Res. Bull. 2006, 69:639-646.
14. Barnes C.A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 1979, 93:74-104.
15. Bayir H., Kagan V.E., Borisenko G.G., Tyurina Y.Y., Janesko K.L., Vagni V.A., Billiar T.R., Williams D.L., Kochanek P.M. Enhanced oxidative stress in iNOS deficient mice after traumatic brain injury: support for a neuroprotective role of iNOS. J. Cereb. Blood Flow Metab. 2005, 25:673-684.
16. Beauchamp K., Mutlak H., Smith W.R., Shohami E., Stahel P.F. Pharmacology of traumatic brain injury: where is the golden bullet?. Mol. Med. 2008, 14:731-740.
17. Besson V.C., Chen X.R., Plotkine M., Marchand-Verrecchia C. Fenofibrate a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury. Neurosci. Lett. 2005, 388:7-12.
18. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851-863.
19. Binder L.M. Persisting symptoms after mild head injury: a review of the postconcussive syndrome. J. Clin. Exp. Neuropsychol. 1986, 8:323-346.
20. Bondi C.O., Cheng J.P., Tennant H.M., Monaco C.M., Kline A.E. Old dog, new tricks: the attentional set-shifting test as a novel cognitive behavioral task after controlled cortical impact injury. J. Neurotrauma 2014, 31:926-937.
21. Bondi C.O., Klitsch K.C., Leary J.B., Kline A.E. Environmental enrichment as a viable neurorehabilitation strategy for experimental traumatic brain injury. J. Neurotrauma 2014, 31:873-888.
22. Bondi C.O., Semple B.D., Noble-Haeusslein L.J., Osier N.D., Carlson S.W., Dixon C.E., Giza C.C., Kline A.E. Found in translation: understanding the biology and behavior of experimental traumatic brain injury. Neurosci. Biobehav. Rev. 2015, 58:123-146.
23. Bondi C.O., Tehranian-DePasquale R., Cheng J.P., Monaco C.M., Griesbach G.S., Kline A.E. Rehabilitative paradigms after experimental brain injury: relevance to human neurotrauma. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects 2015, CRC Press/Taylor & Francis, Boca Raton (FL), (Chapter 34). F.H. Kobeissy (Ed.).
24. Brady K., Garcia T. Constraint-induced movement therapy (CIMT): pediatric applications. Dev. Disabil. Res. Rev. 2009, 15:102-111.
25. Bramlett H.M., Green E.J., Dietrich W.D., Busto R., Globus M.Y., Ginsberg M.D. Posttraumatic brain hypothermia provides protection from sensorimotor and cognitive behavioral deficits. J. Neurotrauma 1995, 12:289-298.
26. Busto R., Dietrich W.D., Globus M.Y.-T., Alonso O., Ginsberg M.D. Extracellular release of serotonin following fluid-percussion brain injury in rats. J. Neurotrauma 1997, 14:35-42.
27. Bye N., Tran M., Malakooti N., Woodcock T., Morganti-Kossmann M.C. Characterising endogenous neurogenesis following experimental focal traumatic brain injury. Injury 2009, 40:S6.
28. Byts N., Siren A.L. Erythropoietin: a multimodal neuroprotective agent. Exp. Transl. Stroke Med. 2009, 1:4.
29. Cacheaux L.P., Ivens S., David Y., Lakhter A.J., Bar-Klein G., Shapira M., Heinemann U., Friedman A., Kaufer D. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J. Neurosci. 2009, 29:8927-8935.
30. Campolo M., Ahmad A., Crupi R., Impellizzeri D., Morabito R., Esposito E., Cuzzocrea S. Combination therapy with melatonin and dexamethasone in a mouse model of traumatic brain injury. J. Endocrinol. 2013, 217:291-301.
31. Carlos T.M., Clark R.S., Franicola-Higgins B.D., Schiding J.K., Kochanek P.M. Expression of endothelial adhesion molecules and recruitment of neutrophils after traumatic brain injury in rats. J. Leuk. Biol. 1997, 61:279-285.
32. Carlson S.W., Madathil S.K., Sama D.M., Gao X., Chen J., Saatman K.E. Conditional overexpression of insulin-like growth factor-1 enhances hippocampal neurogenesis and restores immature neuron dendritic processes after traumatic brain injury. J. Neuropathol. Exp. Neurol. 2014, 73:734-746.
33. Carthew H.L., Ziebell J.M., Vink R. Substance P-induced changes in cell genesis following diffuse traumatic brain injury. Neuroscience 2012, 214:78-83.
34. Çelik S.E., Oztürk H., Tolunay S. Therapeutic effect of hypothermia and dizocilpine maleate on traumatic brain injury in neonatal rats. J. Neurotrauma 2006, 23:1355-1365.
35. Cekic M., Stein D.G. Traumatic brain injury and aging: is a combination of progesterone and vitamin D hormone a simple solution to a complex problem?. Neurotherapeutics 2010, 7:81-90.
36. Cekic M., Sayeed I., Stein D.G. Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front. Neuroendocrinol. 2009, 30:158-172.
37. Cernak I., Noble-Haeusslein L.J. Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J. Cereb. Blood Flow Metab. 2010, 30:255-266.
38. Cernak I. Animal models of head trauma. NeuroRx 2005, 2:410-422.
39. Chauhan N.B., Gatto R. Synergistic benefits of erythropoietin and simvastatin after traumatic brain injury. Brain Res. 2010, 1360:177-192.
40. Chen J., Zhang C., Jiang H., Li Y., Zhang L., Robin A., Katakowski M., Lu M., Chopp M. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J. Cereb. Blood Flow Metab. 2005, 25:281-290.
41. Chen G., Shi J.X., Hang C.H., Xie W., Liu J., Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci. Lett. 2007, 425:177-182.
42. Chen X.R., Besson V.C., Palmier B., Garcia Y., Plotkine M., Marchand-Leroux C. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. J. Neurotrauma 2007, 24:1119-1131.
43. Cheng J.P., Aslam H.A., Hoffman A.N., Zafonte R.D., Kline A.E. The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window. Neurosci. Lett. 2007, 416:165-168.
44. Chen X.R., Besson V.C., Beziaud T., Plotkine M., Marchand-Leroux C. Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury. J. Pharmacol. Exp. Ther. 2008, 326:966-974.
45. Cheng J.P., Hoffman A.N., Zafonte R.D., Kline A.E. A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learning. Behav. Brain Res. 2008, 194:79-85.
46. Cheng J.P., Shaw K.E., Monaco C.M., Hoffman A.N., Sozda C.N., Olsen A.S., Kline A.E. A relatively brief exposure to environmental enrichment after experimental traumatic brain injury confers long-term cognitive benefits. J. Neurotrauma 2012, 29:2684-2688.
47. 1A) receptor agonists: a decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma. Brain Res. 2016, 1640:5-14.
48. Chew E., Zafonte R.D. Pharmacological management of neurobehavioral disorders following traumatic brain injury-a state-of-the-art review. J. Rehabil. Res. Dev. 2009, 46:851-879.
49. Chirumamilla S., Sun D., Bullock M.R., Colello R.J. Traumatic brain injury induced cell proliferation in the adult mammalian central nervous system. J. Neurotrauma 2002, 19:693-703.
50. Ciallella J.R., Yan H.Q., Ma X., Wolfson B.M., Marion D.W., DeKosky S.T., Dixon C.E. Chronic effects of traumatic brain injury on hippocampal vesicular acetylcholine transporter and M2 muscarinic receptor protein in rats. Exp. Neurol. 1998, 152:11-19.
51. Clark R.S., Schiding J., Kaczorowski S.L., Marion D.W., Kochanek P.M. Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. J. Neurotrauma 1994, 11:499-506.
52. Clark R.S., Kochanek P.M., Marion D.W., Schiding J.K., White M., Palmer A.M., DeKosky S.T. Mild posttraumatic hypothermia reduces mortality after severe controlled cortical impact in rats. J. Cereb. Blood Flow Metab. 1996, 16:253-261.
53. Clausen F., Hånell A., Israelsson C., Hedin J., Ebendal T., Mir A.K., Gram H., Marklund N. Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2011, 34:110-123.
54. Clayton E., Kinley-Cooper S.K., Weber R.A., Adkins D.L. Brain stimulation: neuromodulation as a potential treatment for motor recovery following traumatic brain injury. Brain Res. 2016, 1640:130-138.
55. Clifton G.L., Jiang J.Y., Lyeth B.G., Jenkins L.W., Hamm R.J., Hayes R.L. Marked protection by moderate hypothermia after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 1991, 11:114-121.
56. Coimbra C., Drake M., Boris-Moller F., Wieloch T. Long-lasting neuroprotective effect of post-ischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug. Stroke 1996, 27:1578-1585.
57. Cornelius C., Crupi R., Calabrese V., Graziano A., Milone P., Pennisi G., Radak Z., Calabrese E.J., Cuzzocrea S. Traumatic brain injury: oxidative stress and neuroprotection. Antiox. Redox. Signal. 2013, 19:836-853.
58. Coronado, V.G., Xu, L., Basavaraju, S.V., McGuire, L.C., Wald, M.M., Faul, M.D., Guzman, B.R., Hemphill J.D; Centers for Disease Control and Prevention (CDC). 2011. Surveillance for traumatic brain injury-related deaths-United States, 1997-2007. MMWR Surveill. Summ. 60, 1-32.
59. Cucchiara B., Kasner S.E. Use of statins in CNS disorders. J. Neurol. Sci. 2001, 187:81-89.
60. Cui L., Murikinati S.R., Wang D., Zhang X., Duan W.M. Reestablishing neuronal networks in the aged brain by stem cell factor and granulocyte-colony stimulating factor in a mouse model of chronic stroke. PLoS One 2013, 8:e64684.
61. Curia G., Levitt M., Fender J.S., Miller J.W., Ojemann J., D'Ambrosio R. Impact of injury location and severity on posttraumatic epilepsy in the rat: role of frontal neocortex. Cereb. Cortex 2011, 21:1574-1592.
62. Cutler S.M., Cekic M., Miller D.M., Wali B., VanLandingham J.W., Stein D.G. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J. Neurotrauma 2007, 24:1475-1486.
63. de Witt B.W., Ehrenberg K.M., McAloon R.L., Panos A.H., Shaw K.E., Raghavan P.V., Skidmore E.R., Kline A.E. Abbreviated environmental enrichment enhances neurobehavioral recovery comparably to continuous exposure after traumatic brain injury. Neurorehabil. Neural Repair 2011, 25:343-350.
64. D'Ambrosio R., Perucca E. Epilepsy after head injury. Curr. Opin. Neurol. 2004, 17:731-735.
65. D'Ambrosio R., Fairbanks J.P., Fender J.S., Born D.E., Doyle D.L., Miller J.W. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 2004, 127:304-314.
66. Dash P.K., Orsi S.A., Zhang M., Grill R.J., Pati S., Zhao J., Moore A.N. Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One 2010, 5:e11383.
67. De La Peña I., Sanberg P.R., Acosta S., Lin S.Z., Borlongan C.V. G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury. Cell Transplant. 2015, 24:447-457.
68. DeGeorge M.L., Marlowe D., Werner E., Soderstrom K.E., Stock M., Mueller A., Bohn M.C., Kozlowski D.A. Combining glial cell line-derived neurotrophic factor gene delivery (AdGDNF) with L-arginine decreases contusion size but not behavioral deficits after traumatic brain injury. Brain Res. 2011, 1403:45-56.
69. DeKosky S.T., Abrahamson E.E., Ciallella J.R., Paljug W.R., Wisniewski S.R., Clark R.S., Ikonomovic M.D. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch. Neurol. 2007, 64:541-544.
70. Dempsey R.J., Raghavendra Rao V.L. Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats. J. Neurosurg. 2003, 98:867-873.
71. Dietrich W.D., Bramlett H.M. Therapeutic hypothermia and targeted temperature management in traumatic brain injury: clinical challenges for successful translation. Brain Res. 2015, (Epub ahead of print). 10.1016/j.brainres.2015.12.034.
72. Dietrich W.D., Alonso O., Busto R., Finklestein S.P. Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats. J. Neurotrauma 1996, 13:309-316.
73. Dietrich W.D., Busto R., Bethea J.R. Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp. Neurol. 1999, 158:444-450.
74. Dixon C.E., Bao J., Long D.A., Hayes R.L. Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury. Pharmacol. Biochem. Behav. 1996, 53:679-686.
75. Dixon C.E., Flinn P., Bao J., Venya R., Hayes R.L. Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp. Neurol. 1997, 146:479-490.
76. Dixon C.E., Ma X., Marion D.W. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J. Neurotrauma 1997, 14:161-169.
77. Dixon C.E., Ma X., Marion D.W. Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res. 1997, 749:127-130.
78. Dixon C.E., Markgraf C.G., Angileri F., Pike B.R., Wolfson B., Newcomb J.K., Bismar M.M., Blanco A.J., Clifton G.L., Hayes R.L. Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat. J. Neurotrauma 1998, 15:95-103.
79. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
80. Donkin J.J., Nimmo A.J., Cernak I., Blumbergs P.C., Vink R. Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. J. Cereb. Blood Flow Metab. 2009, 29:1388-1398.
81. Donkin J.J., Cernak I., Blumbergs P.C., Vink R. A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. J. Neurotrauma 2011, 28:217-224.
82. Doppenberg E.M., Choi S.C., Bullock R. Clinical trials in traumatic brain injury: lessons for the future. J. Neurosurg. Anesthesiol. 2004, 16:87-94.
83. Dunkerson J., Moritz K.E., Young J., Pionk T., Fink K., Rossignol J., Dunbar G., Smith J.S. Combining enriched environment and induced pluripotent stem cell therapy results in improved cognitive and motor function following traumatic brain injury. Restor. Neurol. Neurosci. 2014, 32:675-687.
84. Dunn-Meynell A., Pan S., Levin B.E. Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 h. Brain Res. 1994, 660:88-95.
85. Ekici M.A., Uysal O., Cikriklar H.I., Özbek Z., Turgut Cosan D., Baydemir C., Kazanci B., Hafizoğlu D. Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury. Eur. Rev. Med. Pharmacol. Sci. 2014, 18:10-27.
86. Engler M.M., Engler M.B., Malloy M.J. Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: endothelial assessment of risk from lipids in youth (EARLY) trial. Circulation 2003, 108:1059-1063.
87. Faden A.I., Demediuk P., Panter S.S., Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989, 244:798-800.
88. Faden A.I. Comparison of single and combination drug treatment strategies in experimental brain trauma. J. Neurotrauma 1993, 10:91-100.
89. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res. Mol. 1995, 30:125-130.
90. Faul M., Xu L., Wald M.M., Coronado V.G. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006 2010, Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
91. Feeney D.M., Gonzalez A., Law W.A. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 1982, 217:855-857.
92. Feeney D.M., Weisend M.P., Kline A.E. Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J. Neural Transplant. Plast. 1993, 4:199-213.
93. Fisher M., Meadows M.E., Do T. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following focal ischemia in rats. J. Cereb. Blood Flow Metab. 1995, 15:953-959.
94. Fleminger S., Oliver D.L., Lovestone S., Rabe-Hesketh S., Giora A. Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J. Neurol. Neurosurg. Psychiatry 2003, 74:857-862.
95. Folweiler K., Bondi C.O., Ogunsanya E., LaPorte M., Leary J., Radabaugh H., Monaco C., Kline A.E. Combining the antipsychotic drug haloperidol and environmental enrichment after traumatic brain injury is a double-edged sword. J. Neurotrauma 2016, (Epub ahead of print).
96. Gao J., Prough D.S., McAdoo D.J., Grady J.J., Parsley M.O., Ma L., Tarensenko Y.I., Wu P. Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. Exp. Neurol. 2006, 201:281-292.
97. Garcia A.N., Shah M.A., Dixon C.E., Wagner A.K., Kline A.E. Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation. PM R 2011, 3:S18-27.
98. Gardner R.C., Burke J.F., Nettiksimmons J., Goldman S., Tanner C.M., Yaffe K. Traumatic brain injury in later life increases risk for Parkinson disease. Ann. Neurol. 2015, 77:987-995.
99. Genovese T., Mazzon E., Crisafulli C., Esposito E., Di Paola R., Muia C., Di Bella P., Bramanti P., Cuzzocrea S. Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J. Pineal Res. 2007, 43:140-153.
100. Gisvold S.E., Safar P., Rao G., Moossy J., Kelsey S., Alexander H. Multifaceted therapy after global brain ischemia in monkeys. Stroke 1984, 15:803-812.
101. Goda M., Isono M., Fujiki M., Kobayashi H. Both MK801 and NBQX reduce the neuronal damage after impact-acceleration brain injury. J. Neurotrauma 2002, 19:1445-1456.
102. Goldman S.M., Tanner C.M., Oakes D., Bhudhikanok G.S., Gupta A., Langston J.W. Head injury and Parkinson's disease risk in twins. Ann. Neurol. 2006, 60:65-72.
103. Gopez J.J., Yue H., Vasudevan R., Malik A.S., Fogelsanger L.N., Lewis S., Panikashvili D., Shohami E., Jansen S.A., Narayan R.K., Strauss K.I. Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. Neurosurgery 2005, 56:590-604.
104. Greve M.W., Zink B.J. Pathophysiology of traumatic brain injury. Mt. Sinai J. Med. 2009, 76:97-104.
105. Griesbach G.S., Hovda D.A., Molteni R., Wu A., Gomez-Pinilla F. Voluntary exercise following traumatic brain injury: brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience 2004, 125:129-139.
106. Griesbach G.S., Hovda D.A., Gomez-Pinilla F., Sutton R.L. Voluntary exercise or amphetamine treatment, but not the combination, increases hippocampal brain-derived neurotrophic factor and synapsin I following cortical contusion injury in rats. Neuroscience 2008, 154:530-540.
107. Griesbach G.S., Tio D.L., Vincelli J., McArthur D.L., Taylor A.N. Differential effects of voluntary and forced exercise on stress responses after traumatic brain injury. J. Neurotrauma 2012, 29:1426-1433.
108. Griesbach G.S., Kreber L.A., Harrington D., Ashley M.J. Post-acute traumatic brain injury rehabilitation: effects on outcome measures and life care costs. J. Neurotrauma 2015, 32:704-711.
109. Guluma K.Z., Saatman K.E., Brown A., Raghupathi R., McIntosh T.K. Sequential pharmacotherapy with magnesium chloride and basic fibroblast growth factor after fluid percussion brain injury results in less neuromotor efficacy than that achieved with magnesium alone. J. Neurotrauma 1999, 16:311-321.
110. Gupta R., Sen N. Traumatic brain injury: a risk factor for neurodegenerative diseases. Rev. Neurosci. 2016, 27:93-100.
111. Guseva M.V., Hopkins D.M., Scheff S.W., Pauly J.R. Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury. J. Neurotrauma 2008, 25:975-983.
112. Haber M., Abdel Baki S.G., Grin'kina N.M., Irizarry R., Ershova A., Orsi S., Grill R.J., Dash P., Bergold P.J. Minocycline plus N-acetylcysteine synergize to modulate inflammation and prevent cognitive and memory deficits in a rat model of mild traumatic brain injury. Exp. Neurol. 2013, 249:169-177.
113. Hall E.D., Kupina N.C., Althaus J.S. Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann. N.Y. Acad. Sci. 1999, 890:462-468.
114. Hamm R.J., Temple M.D., O'Dell D.M., Pike B.R., Lyeth B.G. Exposure to environmental complexity promotes recovery of cognitive function after traumatic brain injury. J. Neurotrauma 1996, 13:41-47.
115. Han R.Z., Hu J.J., Weng Y.C., Li D.F., Huang Y. NMDA receptor antagonist MK-801 reduces neuronal damage and preserves learning and memory in a rat model of traumatic brain injury. Neurosci. Bull. 2009, 25:367-375.
116. Hayes R.L., Jenkins L.W., Lyeth B.G. Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids. J. Neurotrauma 1992, 1:S173-187.
117. Heegaard W., Biros M., Zink J. Effect of hypothermia dichloroacetate, and deferoxamine in the treatment for cortical edema and functional recovery after experimental cortical impact in the rat. Acad. Emerg. Med. 1997, 4:33-39.
118. Hellewell S., Semple B.D., Morganti-Kossmann M.C. Therapies negating neuroinflammation after brain trauma. Brain Res. 2016, 1640:36-56.
119. Henkel J. Attacking AIDS with a 'cocktail' therapy?. FDA Consum. 1999, 33:12-17.
120. Hernandez T.D. Post-traumatic neural depression and neurobehavioral recovery after brain injury. J. Neurotrauma 2006, 23:1211-1221.
121. Hinzman J.M., Thomas T.C., Burmeister J.J., Quintero J.E., Huettl P., Pomerleau F., Gerhardt G.A., Lifshitz J. Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study. J. Neurotrauma 2010, 27:889-899.
122. Hinzman J.M., Thomas T.C., Quintero J.E., Gerhardt G.A., Lifshitz J. Disruptions in the regulation of extracellular glutamate by neurons and glia in the rat striatum two days after diffuse brain injury. J. Neurotrauma 2012, 29:1197-1208.
123. Hoane M.R., Akstulewicz S.L., Toppen J. Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats. J. Neurotrauma 2003, 20:1189-1199.
124. Hoane M.R., Wolyniak J.G., Akstulewicz S.L. Administration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidic protein expression after traumatic brain injury. J. Neurotrauma 2005, 22:1112-1122.
125. Hoane M.R., Gilbert D.R., Holland M.A., Pierce J.L. Nicotinamide reduces acute cortical neuronal death and edema in the traumatically injured brain. Neurosci. Lett. 2006, 408:35-39.
126. Hoane M.R., Pierce J.L., Holland M.A., Anderson G.D. Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat. Neuroscience 2008, 154:861-868.
127. Hoffman A.N., Cheng J.P., Zafonte R.D., Kline A.E. Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sci. 2008, 83:602-607.
128. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Ann. Rev. Neurosci. 2001, 24:677-736.
129. Hyder A.A., Wunderlich C.A., Puvanachandra P., Gururaj G., Kobusingye O.C. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 2007, 22:341-353.
130. Ikonomovic M.D., Uryu K., Abrahamson E.E., Ciallella J.R., Trojanowski J.Q., Lee V.M., Clark R.S., Marion D.W., Wisniewski S.R., DeKosky S.T. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 2004, 190:192-203.
131. Itoh T., Imano M., Nishida S., Tsubaki M., Hashimoto S., Ito A., Satou T. Exercise inhibits neuronal apoptosis and improves cerebral function following rat traumatic brain injury. J. Neural Transm. (Vienna) 2011, 118:1263-1272.
132. Jacotte-Simancas A., Costa-Miserachs D., Coll-Andreu M., Torras-Garcia M., Borlongan C.V., Portell-Cortés I. Effects of voluntary physical exercise, citicoline, and combined treatment on object recognition memory, neurogenesis, and neuroprotection after traumatic brain injury in rats. J. Neurotrauma 2015, 32:739-751.
133. Ji Z., Liu K., Cai L., Peng C., Xin R., Gao Z., Zhao E., Rastogi R., Han W., Rafols J.A., Geng X., Ding Y. Therapeutic effect of tPA in ischemic stroke is enhanced by its combination with normobaric oxygen and hypothermia or ethanol. Brain Res. 2015, 1627:31-40.
134. Jing C.H., Wang L., Liu P.P., Wu C., Ruan D., Chen G. Autophagy activation is associated with neuroprotection against apoptosis via a mitochondrial pathway in a rat model of subarachnoid hemorrhage. Neuroscience 2012, 213:144-153.
135. Johansson B., Wentzel A.P., Andréll P., Mannheimer C., Rönnbäck L. Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury. Brain Inj. 2015, 29:758-765.
136. Johnson V.E., Meaney D.F., Cullen D.K., Smith D.H. Animal models of traumatic brain injury. Handb. Clin. Neurol. 2015, 127:115-128.
137. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr. Opin. Neurobiol. 2000, 10:381-391.
138. Kelso M.L., Scheff N.N., Scheff S.W., Pauly J.R. Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury. Neurosci. Lett. 2011, 488:60-64.
139. Kim K.S., Wass C.A., Cross A.S., Opal S.M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 1992, 11:293-298.
140. Kline A.E., Dixon C.E. Contemporary in vivo models of brain trauma and a comparison of injury responses. Head Trauma: Basic, Preclinical, and Clinical Directions 2001, 65-84. John Wiley & Sons, Inc., New York, NY. L.P. Miller, R.L. Hayes (Eds.).
141. Kline A.E., Chen M.J., Tso-Olivas D.Y., Feeney D.M. Methylphenidate treatment following ablation-induced hemiplegia in rat: experience during drug action alters effects on recovery of function. Pharmacol. Biochem. Behav. 1994, 48:773-779.
142. Kline A.E., Yan H.W., Bao J., Marion D.W., Dixon C.E. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci. Lett. 2000, 280:163-166.
143. Kline A.E., Bolinger B.D., Kochanek P.M., Carlos T.M., Yan H.Q., Jenkins L.W., Marion D.W., Dixon C.E. Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res. 2002, 937:22-31.
144. Kline A.E., Massucci J.L., Zafonte R.D., Dixon C.E., DeFeo J.R., Rogers E.H. Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma. Crit. Care Med. 2007, 35:919-924.
145. Kline A.E., Wagner A.K., Westergom B.P., Malena R.R., Zafonte R.D., Olsen A.S., Sozda C.N., Luthra P., Panda M., Cheng J.P., Aslam H.A. Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma. Behav. Brain Res. 2007, 177:186-194.
146. Kline A.E., Hoffman A.N., Cheng J.P., Zafonte R.D., Massucci J.L. Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury. Neurosci. Lett. 2008, 448:263-267.
147. Kline A.E., McAloon R.L., Henderson K.A., Bansal U.K., Ganti B.M., Ahmed R.H., Gibbs R.B., Sozda C.N. Evaluation of a combined therapeutic regimen of 8-OH-DPAT and environmental enrichment after experimental traumatic brain injury. J. Neurotrauma 2010, 27:2021-2032.
148. Kline A.E., Olsen A.S., Sozda C.N., Hoffman A.N., Cheng J.P. Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury. J. Neurotrauma 2012, 29:1960-1969.
149. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 1998, 153:143-151.
150. Koizumi H., Povlishock J.T. Posttraumatic hypothermia in the treatment of axonal damage in an animal model of traumatic axonal injury. J. Neurosurg. 1998, 89:303-309.
151. Kokiko O.N., Hamm R.J. A review of pharmacological treatments used in experimental models of traumatic brain injury. Brain Inj. 2007, 21:259-274.
152. Kokiko-Cochran O.N., Michaels M.P., Hamm R.J. Delayed glucose treatment improves cognitive function following fluid-percussion injury. Neurosci. Lett. 2008, 436:27-30.
153. Koopmans G.C., Deumens R., Buss A., Geoghegan L., Myint A.M., Honig W.H., Kern N., Joosten E.A., Noth J., Brook G.A. Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury. Exp. Neurol. 2009, 216:490-498.
154. Kreber L.A., Griesbach G.S. The interplay between neuropathology and activity based rehabilitation after traumatic brain injury. Brain Res. 2014, 1640:152-163.
155. Lam T.I., Bingham D., Chang T.J., Lee C.C., Shi J., Wang D., Massa S., Swanson R.A., Liu J. Beneficial effects of minocycline and botulinum toxin-induced constraint physical therapy following experimental traumatic brain injury. Neurorehab. Neural Repair 2013, 27:889-899.
156. Laskowski R.A., Creed J.A., Raghupathi R. Pathophysiology of mild TBI: Implications for altered signaling pathways. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects 2015, CRC Press/Taylor & Francis, Boca Raton (FL), (Chapter 4. Frontiers in Neuroengineering). F.H. Kobeissy (Ed.).
157. Lau A., Tymianski M. Glutamate receptors: neurotoxicity and neurodegeneration. Pflügers Arch. 2010, 460:525-542.
158. Lawrence C.B., Allan S.M., Rothwell N.J. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 1998, 10:1188-1195.
159. Leary J., Bondi C.O., LaPorte M., Carlson L.J., Radabaugh H., Cheng J.P., Kline A.E. The therapeutic efficacy of environmental enrichment and methylphenidate alone and in combination after controlled cortical impact injury. J. Neurotrauma 2016, (Epub ahead of print).
160. Lee S.M., Wong M.D., Samii A., Hovda D.A. Evidence for energy failure following irreversible traumatic brain injury. Ann. N. Y. Acad. Sci. 1999, 893:337-340.
161. Lee H.J., Bian S., Jakovcevski I., Wu B., Irintchev A., Schachner M. Delayed applications of L1 and chondroitinase ABC promote recovery after spinal cord injury. J. Neurotrauma 2012, 29:1850-1863.
162. Li Z.Q., Liang G.B., Xue Y.X., Liu Y.H. Effects of combination treatment of dexamethasone and melatonin on brain injury in intracerebral hemorrhage model in rats. Brain Res. 2009, 1264:98-103.
163. Li F., Zhao C., Wang L. Molecular-targeted agents combination therapy for cancer: developments and potentials. Int. J. Cancer 2014, 134:1257-1269.
164. Li T., Wang D., Tian Y., Yu H., Wang Y., Quan W., Cui W., Zhou L., Chen J., Jiang R., Zhang J. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats. J. Neurol. Sci. 2014, 341:88-96.
165. Li S., Zaninotto A.L., Neville I.S., Paiva W.S., Nunn D., Fregni F. Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence. Neuropsychiatr. Dis. Treat. 2015, 11:1573-1586.
166. Ling G., Bandak F., Armonda R., Grant G., Ecklund J. Explosive blast neurotrauma. J. Neurotrauma 2009, 26:815-825.
167. Liu R., Liu Q., He S., Simpkins J.W., Yang S.H. Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J. Pharmacol. Exp. Ther. 2010, 332:1006-1012.
168. Lombard L.A., Zafonte R.D. Agitation after traumatic brain injury: considerations and treatment options. Am. J. Phys. Med. Rehabil. 2005, 84:797-812.
169. Lu D., Goussev A., Chen J., Pannu P., Li Y., Mahmood A., Chopp M. Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J. Neurotrauma 2004, 21:21-32.
170. Lu D., Qu C., Goussev A., Jiang H., Lu C., Schallert T., Mahmood A., Chen J., Li Y., Chopp M. Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J. Neurotrauma 2007, 24:1132-1146.
171. Lucas S.M., Rothwell N.J., Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 2006, 147:S232-S240.
172. Lyeth B.G., Liu S., Hamm R.J. Combined scopolamine and morphine treatment of traumatic brain injury in the rat. Brain Res. 1993, 617:69-75.
173. Maegele M., Lippert-Gruener M., Ester-Bode T., Garbe J., Bouillon B., Neugebauer E., Klug N., Lefering R., Neiss W.F., Angelov D.N. Multimodal early onset stimulation combined with enriched environment is associated with reduced CNS lesion volume and enhanced reversal of neuromotor dysfunction after traumatic brain injury in rats. Eur. J. Neurosci. 2005, 21:2406-2418.
174. Mahmood A., Lu D., Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma 2004, 21:33-39.
175. Mahmood A., Lu D., Qu C., Goussev A., Chopp M. Treatment of traumatic brain injury with a combination therapy of marrow stromal cells and atorvastatin in rats. Neurosurgery 2007, 60:546-553.
176. Mahmood A., Goussev A., Lu D., Qu C., Xiong Y., Kazmi H., Chopp M. Long-lasting benefits after treatment of traumatic brain injury (TBI) in rats with combination therapy of marrow stromal cells (MSCs) and simvastatin. J. Neurotrauma 2008, 25:1441-1447.
177. Margulies S., Hicks R., Combination Therapies for Traumatic Brain Injury Workshop Leaders Combination therapies for traumatic brain injury: prospective considerations. J. Neurotrauma 2009, 26:925-939.
178. Marklund N., Hillered L. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?. Br. J. Pharmacol. 2011, 164:1207-1229.
179. Markos S.M., Failla M.D., Ritter A.C., Dixon C.E., Conley Y.P., Ricker J.H., Arenth P.M., Juengst S.B., Wagner A.K. Genetic variation in the vesicular monoamine transporter: preliminary associations with cognitive outcomes after severe traumatic brain injury. J. Head Trauma Rehabil. 2016, (Epub ahead of print).
180. Marras C., Hincapié C.A., Kristman V.L., Cancelliere C., Soklaridis S., Li A., Borg J., af Geijerstam J.L., Cassidy J.D. Systematic review of the risk of Parkinson's disease after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Arch. Phys. Med. Rehabil. 2014, 95:S238-S244.
181. Massucci J.L., Kline A.E., Ma X., Zafonte R.D., Dixon C.E. Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci. Lett. 2004, 372:127-131.
182. Matter A.M., Folweiler K.A., Curatolo L.M., Kline A.E. Temporal effects of environmental enrichment-mediated functional improvement after experimental traumatic brain injury in rats. Neurorehabil. Neural Repair 2011, 25:558-564.
183. Max W., MacKenzie E.J., Rice C.P. Head injuries: costs and consequences. J. Head Trauma Rehabil. 1991, 6:76-91.
184. McDermott K.L., Raghupathi R., Fernandez S.C., Saatman K.E., Protter A.A., Finklestein S.P., Sinson G., Smith D.H., McIntosh T.K. Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat. J. Neurotrauma 1997, 14:191-200.
185. McDonald J.W., Silverstein F.S., Johnston M.V. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res. 1988, 459:200-203.
186. McGirt M.J., Lynch J.R., Parra A., Sheng H., Pearlstein R.D., Laskowitz D.T., Pelligrino D.A., Warner D.S. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 2002, 33:2950-2956.
187. McIntosh T.K., Yu T., Gennarelli T.A. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J. Neurochem. 1994, 63:1426-1433.
188. McIntosh T.K., Juhler M., Wieloch T. Novel pharmacologic strategies in the treatment of experimental traumatic brain injury: 1998. J. Neurotrauma 1998, 15:731-769.
189. McNett M., Sarver W., Wilczewski P. The prevalence: treatment and outcomes of agitation among patients with brain injury admitted to acute care units. Brain Inj. 2012, 26:1155-1162.
190. Menkü A., Koç R.K., Tayfur V., Saraymen R., Narin F., Akdemir H. Effects of mexiletine, ginkgo biloba extract (EGb 761), and their combination on experimental head injury. Neurosurg. Rev. 2003, 26:288-291.
191. Menon D.K., Zahed C. Prediction of outcome in severe traumatic brain injury. Curr. Opin. Crit. Care 2009, 15:437-441.
192. Millis S.R., Rosenthal M., Novack T.A., Sherer M., Nick T.G., Kreutzer J.S., High W.M., Ricker J.H. Long-term neuropsychological outcome after traumatic brain injury. J. Head Trauma Rehabil. 2001, 16:343-355.
193. Minnich J.E., Mann S.L., Stock M., Stolzenbach K.A., Mortell B.M., Soderstrom K.E., Bohn M.C., Kozlowski D.A. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury. Restor. Neurol. Neurosci. 2010, 28:293-309.
194. Monaco C.M., Mattiola V.V., Folweiler K.A., Tay J.K., Yelleswarapu N.K., Curatolo L.M., Matter A.M., Cheng J.P., Kline A.E. Environmental enrichment promotes robust functional and histological benefits in female rats after controlled cortical impact injury. Exp. Neurol. 2013, 247:410-418.
195. Monaco C.M., Gebhardt K.M., Chlebowski S.M., Shaw K.E., Cheng J.P., Henchir J.J., Zupa M.F., Kline A.E. A combined therapeutic regimen of buspirone and environmental enrichment is more efficacious than either alone in enhancing spatial learning in brain-injured pediatric rats. J. Neurotrauma 2014, 31:1934-1941.
196. Morales D.M., Marklund N., Lebold D., Thompson H.J., Pitkanen A., Maxwell W.L., Longhi L., Laurer H., Maegele M., Neugebauer E., Graham D.I., Stocchetti N., McIntosh T.K. Experimental models of traumatic brain injury: do we really need to build a better mousetrap?. Neuroscience 2005, 136:971-989.
197. Morganti-Kossmann M.C., Rancan M., Stahel P.F., Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 2002, 8:101-105.
198. Morganti-Kossmann M.C., Yan E., Bye N. Animal models of traumatic brain injury: is there an optimal model to reproduce human brain injury in the laboratory?. Injury 2010, 41:S10-13.
199. Na K.S., Jung H.Y., Lee S.I., Kim S.G. Mediating effects of cognitive effort and depression on intelligence memory, and executive functions in individuals with mild traumatic brain injury. Psychiatry Investig. 2014, 11:112-118.
200. Nakata N., Kato H., Kogure K. Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res. 1993, 605:354-356.
201. Nemati F., Kolb B. FGF-2 induces behavioral recovery after early adolescent injury to the motor cortex of rats. Behav. Brain Res. 2011, 225:184-191.
202. Ng S.Y., Semple B., Morganti-Kossmann M.C., Bye N. Attenuation of microglial activation with minocycline is not associated with changes in neurogenesis after focal traumatic brain injury in adult mice. J. Neurotrauma 2012, 29:1410-1425.
203. Nudi E.T., Jacqmain J., Dubbs K., Geeck K., Salois G., Searles M.A., Smith J.S. Combining enriched environment, progesterone, and embryonic neural stem cell therapy improves recovery following brain injury. J. Neurotrauma 2014, 32:1117-1129.
204. 1A receptor agonist buspirone. J. Neurotrauma 2012, 29:1898-1907.
205. Oron A., Oron U., Streeter J., De Taboada L., Alexandrovich A., Trembovler V., Shohami E. Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury significantly reduces long-term neurological deficits. J. Neurotrauma 2012, 29:401-407.
206. Osier N.D., Dixon C.E. Catecholaminergic based therapies for functional recovery after TBI. Brain Res. 2015, (Epub ahead of print). 10.1016/j.brainres.2015.12.026.
207. Ozdemir D., Tugyan K., Uysal N., Sonmez U., Sonmez A., Acikgoz O., Ozdemir N., Duman M., Ozkan H. Protective effect of melatonin against head trauma-induced hippocampal damage and spatial memory deficits in immature rats. Neurosci. Lett. 2005, 385:234-239.
208. Ozdemir D., Baykara B., Aksu I., Kiray M., Sisman A.R., Cetin F., Dayi A., Gurpinar T., Uysal N., Arda M.N. Relationship between circulating IGF-1 levels and traumatic brain injury-induced hippocampal damage and cognitive dysfunction in immature rats. Neurosci. Lett. 2012, 507:84-89.
209. Oztürk E., Demirbilek S., Köroğlu A., But A., Begeç Z.O., Gülec M., Akyol O., Ersoy M.O. Propofol and erythropoietin antioxidant properties in rat brain injured tissue: prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:81-86.
210. Park S.W., Yan Y.P., Satriotomo I., Vemuganti R., Dempsey R.J. Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J. Neurosurg. 2007, 107:593-599.
211. Parton A., Coulthard E., Husain M. Neuropharmacological modulation of cognitive deficits after brain damage. Curr. Opin. Neurol. 2005, 18:675-680.
212. Passineau M.J., Green E.J., Dietrich W.D. Therapeutic effects of environmental enrichment on cognitive function and tissue integrity following severe traumatic brain injury in rats. Exp. Neurol. 2001, 168:373-384.
213. Patel K., Sun D. Strategies targeting endogenous neurogenic cell response to improve recovery following traumatic brain injury. Brain Res. 2016, (Epub ahead of print). 10.1016/j.brainres.2016.01.055.
214. Peruzzaro S.T., Gallagher J., Dunkerson J., Fluharty S., Mudd D., Hoane M.R., Smith J.S. The impact of enriched environment and transplantation of murine cortical embryonic stem cells on recovery from controlled cortical contusion injury. Restor. Neurol. Neurosci. 2013, 31:431-450.
215. Peterson T.C., Anderson G.D., Kantor E.D., Hoane M.R. A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat. J. Neurotrauma 2012, 29:2823-2830.
216. Peterson T.C., Hoane M.R., McConomy K.S., Farin F.M., Bammler T.K., MacDonald J.W., Kantor E.D., Anderson G.D. A combination therapy of nicotinamide and progesterone improves functional recovery following traumatic brain injury. J. Neurotrauma 2015, 32:765-779.
217. Phelps T.I., Bondi C.O., Ahmed R.H., Olugbade Y.T., Kline A.E. Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficits. J. Neurotrauma 2015, 32:590-597.
218. Ponsford J., Cameron P., Fitzgerald M., Grant M., Mikocka-Walus A., Schönberger M. Predictors of postconcussive symptoms 3 months after mild traumatic brain injury. Neuropsychology 2012, 26:304-313.
219. Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol. 2004, 14:215-222.
220. Rao V., Koliatsos V., Ahmed F., Lyketsosm C., Kortte K. Neuropsychiatric disturbances associated with traumatic brain injury: a practical approach to evaluation and management. Semin. Neurol. 2015, 35:64-82.
221. Richardson R.M., Singh A., Sun D., Fillmore H.L., Dietrich W.D., Bullock M.R. Stem cell biology in traumatic brain injury: effects of injury and strategies for repair. J. Neurosurg. 2009, 112:1125-1138.
222. Riess P., Molcanyi M., Bentz K., Maegele M., Simanski C., Carlitscheck C., Schneider A., Hescheler J., Bouillon B., Schafer U., Neugebauer E. Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors. J. Neurotrauma 2007, 24:216-225.
223. Rogers J.M., Read C.A. Psychiatric comorbidity following traumatic brain injury. Brain Inj. 2007, 21:1321-1333.
224. Rose M.E., Huerbin M.B., Melick J., Marion D.W., Palmer A.M., Schiding J.K., Kochanek P.M., Graham S.H. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002, 935:40-46.
225. Sánchez-Moreno C., Dashe J.F., Scott T., Thaler D., Folstein M.F., Martin A. Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 2004, 35:163-168.
226. Sönmez A., Sayin O., Gürgen S.G., Çalişir M. Neuroprotective effects of MK-801 against traumatic brain injury in immature rats. Neurosci. Lett. 2015, 597:137-142.
227. Saatman K.E., Contreras P.C., Smith D.H., Raghupathi R., McDermott K.L., Fernandez S.C., Sanderson K.L., Voddi M., McIntosh T.K. Insulin-like growth factor-1 (IGF-1) improves both neurological motor and cognitive outcome following experimental brain injury. Exp. Neurol. 1997, 147:418-427.
228. Sanchez-Ramos J., Song S., Sava V., Catlow B., Lin X. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience 2009, 163:55-72.
229. Schaeffer E.L., Forlenza O.V., Gattaz W.F. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Psychopharmacology 2009, 202:37-51.
230. Schofield P.W., Tang M., Marder K., Bell K., Dooneief G., Chun M., Sano M., Stern Y., Mayeux R. Alzheimer's disease after remote head injury: an incidence study. J. Neurol. Neurosurg. Psychiatry 1997, 62:119-124.
231. Scholten A.C., Haagsma J.A., Cnossen M.C., Olff M., Van Beeck E.F., Polinder S. Prevalence and risk factors of anxiety and depressive disorders following traumatic brain injury: a systematic review. J. Neurotrauma 2016, (Epub ahead of print).
232. Schuch C.P., Jeffers M.S., Antonescu S., Nguemeni C., Gomez-Smith M., Pereira L.O., Morshead C.M., Corbett D. Enriched rehabilitation promotes motor recovery in rats exposed to neonatal hypoxia-ischemia. Behav. Brain Res. 2016, 304:42-50.
233. Scott G., Ramlackhansingh A.F., Edison P., Hellyer P., Cole J., Veronese M., Leech R., Greenwood R.J., Turkheimer F.E., Gentleman S.M., Heckemann R.A., Matthews P.M., Brooks D.J., Sharp D.J. Amyloid pathology and axonal injury after brain trauma. Neurology 2016, 86:821-828.
234. Selassie A.W., Zaloshnja E., Langlois J.A., Miller T., Jones P., Steiner C. Incidence of long-term disability following traumatic brain injury hospitalization, United States, 2003. J. Head Trauma Rehabil. 2008, 23:123-131.
235. Shapira Y., Yadid G., Cotev S., Niska A., Shohami E. Protective effect of MK801 in experimental brain injury. J. Neurotrauma 1990, 7:131-139.
236. Shohami E., Bass R., Wallach D., Yamin A., Gallily R. Inhibition of tumor necrosis factor alpha (TNF alpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 1996, 16:378-384.
237. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J. Neuroimmunol. 1997, 72:169-177.
238. Sinson G., Perri B.R., Trojanowski J.Q., Flamm E.S., McIntosh T.K. Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury. J. Neurosurg. 1997, 86:511-518.
239. Smith D.H., Okiyama K., Gennarelli T.A., McIntosh T.K. Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury. Neurosci. Lett. 1993, 157:211-214.
240. Soares H.D., Hicks R.R., Smith D., McIntosh T.K. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J. Neurosci. 1995, 15:8223-8233.
241. Sosin D.M., Sniezek J.E., Thurman D.J. Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj. 1996, 10:47-54.
242. Sozda C.N., Hoffman A.N., Olsen A.S., Cheng J.P., Zafonte R.D., Kline A.E. Empirical comparisons of typical and atypical environmental enrichment paradigms on functional and histological outcome after experimental traumatic brain injury. J. Neurotrauma 2010, 27:1047-1057.
243. Spera P.A., Ellison J.A., Feuerstein G.Z., Barone F.C. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 1998, 251:189-192.
244. Stein D.G., Cekic M.M. Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged. PM R 2011, 3:S100-110.
245. Stein D.G. Embracing failure: what the phase III progesterone studies can teach about TBI clinical trials. Brain Inj. 2015, 29:1259-1272.
246. Stover J.F., Unterberg A.W. Increased cerebrospinal fluid glutamate and taurine concentrations are associated with traumatic brain edema formation in rats. Brain Res. 2000, 875:51-55.
247. Stover J.F., Morganti-Kosmann M.C., Lenzlinger P.M., Stocker R., Kempski O.S., Kossmann T. Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients. J. Neurotrauma 1999, 16:135-142.
248. Sullivan P., Petitti D., Barbaccia J. Head trauma and age of onset of dementia of the Alzheimer type. JAMA 1987, 257:2289-2290.
249. Summers C.R., Ivins B., Schwab K.A. Traumatic brain injury in the United States: an epidemiologic overview. Mt. Sinai J. Med. 2009, 76:105-110.
250. Tanabe M., Ono K., Honda M., Ono H. Gabapentin and pregabalin ameliorate mechanical hypersensitivity after spinal cord injury in mice. Eur. J. Pharmacol. 2009, 609:65-68.
251. Taylor K.M., Saint-Hilaire M.H., Sudarsky L., Simon D.K., Hersh B., Sparrow D., Hu H., Weisskopf M.G. Head injury at early ages is associated with risk of Parkinson's disease. Parkinsonism Relat. Disord. 2016, 23:57-61.
252. Temple M.D., Hamm R.J. Chronic post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury. Brain Res. 1996, 741:246-251.
253. Thau-Zuchman O., Shohami E., Alexandrovich A.G., Leker R.R. Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury. J. Mol. Neurosci. 2012, 47:166-172.
254. Thurman D., Guerrero J. Trends in hospitalization associated with traumatic brain injury. JAMA 1999, 282:954-957.
255. Todd M.M., Cutkomp J., Brian J.E. Influence of mannitol and furosemide alone and in combination, on brain water content after fluid percussion injury. Anesthesiology 2006, 105:1176-1181.
256. Uysal N., Baykara B., Kiray M., Cetin F., Aksu I., Dayi A., Gurpinar T., Ozdemir D., Arda M.N. Combined treatment with progesterone and magnesium sulfate positively affects traumatic brain injury in immature rats. Turk. Neurosurg. 2013, 23:129-137.
257. Valle-Prieto A., Conget P.A. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev. 2010, 19:1885-1893.
258. van Praag H., Schinder A.F., Christie B.R., Toni N., Palmer T.D., Gage F.H. Functional neurogenesis in the adult hippocampus. Nature 2002, 415:1030-1034.
259. Veenith T., Goon S.S., Burnstein R.M. Molecular mechanisms of traumatic brain injury: the missing link in management. World J. Emerg. Surg. 2009, 4:7.
260. Vonder Haar C., Anderson G.D., Hoane M.R. Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury. Behav. Brain Res. 2011, 224:311-317.
261. Vonder Haar C., Maass W.R., Jacobs E.A., Hoane M.R. Deficits in discrimination after experimental frontal brain injury are mediated by motivation and can be improved by nicotinamide administration. J. Neurotrauma 2014, 31:1711-1720.
262. Vonder Haar C., Peterson T.C., Martens K.M., Hoane M.R. Vitamins and nutrients as primary treatments in experimental brain injury: clinical implications for nutraceutical therapies. Brain Res. 2016, 1640:114-129.
263. Wagner A.K., Kline A.E., Ren D., Willard L.A., Wenger M.K., Zafonte R.D., Dixon C.E. Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury. Behav. Brain Res. 2007, 181:200-209.
264. Wang L.C., Huang C.Y., Wang H.K., Wu M.H., Tsai K.J. Magnesium sulfate and nimesulide have synergistic effects on rescuing brain damage after transient focal ischemia. J. Neurotrauma 2012, 29:1518-1529.
265. Wang K.W., Wang H.K., Chen H.J., Liliang P.C., Liang C.L., Tsai Y.D., Cho C.L., Lu K. Simvastatin combined with antioxidant attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury. Biomed. Res. Int. 2014, Epub 2014. 10.1155/2014/910260.
266. Warren A.M., Boals A., Elliott T.R., Reynolds M., Weddle R.J., Holtz P., Trost Z., Foreman M.L. Mild traumatic brain injury increases risk for the development of posttraumatic stress disorder. J. Trauma Acute Care Surg. 2015, 79:1062-1066.
267. Weitz-Schmidt G., Welzenbach K., Brinkmann V., Kamata T., Kallen J., Bruns C., Cottens S., Takada Y., Hommel U. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 2001, 7:687-692.
268. Werner C., Engelhard K. Pathophysiology of traumatic brain injury. Br. J. Anaesth. 2007, 99:4-9.
269. Wheaton P., Mathias J.L., Vink R. Impact of early pharmacotherapy treatment on cognitive and behavioral outcome after traumatic brain injury in adults: a meta-analysis. J. Clin. Psychopharmacol. 2009, 29:468-477.
270. Whyte J., Hart T., Vaccaro M., Grieb-Neff P., Risser A., Polansky M., Coslett H.B. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional randomized, controlled trial. Am. J. Phys. Med. Rehabil. 2004, 83:401-420.
271. Wilems T.S., Pardieck J., Iyer N., Sakiyama-Elbert S.E. Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury. Acta Biomater. 2015, 28:23-32.
272. Willmott C., Ponsford J. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial. J. Neurol. Neurosurg. Psychiatry 2009, 80:552-557.
273. Wilson M.S., Gibson C.J., Hamm R.J. Haloperidol but not olanzapine, impairs cognitive performance after traumatic brain injury in rats. Am. J. Phys. Med. Rehabil. 2003, 82:871-879.
274. Wu A., Ying Z., Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress synaptic plasticity, and cognition. Exp. Neurol. 2006, 197:309-317.
275. Wu A., Ying Z., Gomez-Pinilla F. Exercise facilitates the action of dietary DHA on functional recovery after brain trauma. Neuroscience 2013, 248:655-663.
276. Wu A., Ying Z., Gomez-Pinilla F. Dietary strategy to repair plasma membrane after brain trauma: implications for plasticity and cognition. Neurorehabil. Neural Repair 2014, 28:75-84.
277. Xiong Y., Mahmood A., Qu C., Kazmi H., Zhang Z.G., Noguchi C.T., Schallert T., Chopp M. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J. Neurotrauma 2010, 27:205-215.
278. Xuan W., Vatansever F., Huang L., Wu Q., Xuan Y., Dai T., Ando T., Xu T., Huang Y.Y., Hamblin M.R. Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen. PLoS One 2013, 8:e53454.
279. Yan H.Q., Yu J., Kline A.E., Letart P., Jenkins L.W., Marion D.W., Dixon C.E. Evaluation of combined fibroblast growth factor-2 and moderate hypothermia therapy in traumatically brain injured rats. Brain Res. 2000, 887:134-143.
280. Young L., Rule G.T., Bocchieri R.T., Walilko T.J., Burns J.M., Ling G. When physics meets biology: low and high-velocity penetration, blunt impact, and blast injuries to the brain. Front. Neurol. 2015, 6:89.
281. Yu F., Wang Z., Tchantchou F., Chiu C.T., Zhang Y., Chuang D.M. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. J. Neurotrauma 2012, 29:362-374.
282. Yu F., Wang Z., Tanaka M., Chiu C.T., Leeds P., Zhang Y., Chuang D.M. Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury. J. Neurosurg. 2013, 119:766-773.
283. Zafonte R.D., Bagiella E., Ansel B.M., Novack T.A., Friedewald W.T., Hesdorffer D.C., Timmons S.D., Jallo J., Eisenberg H., Hart T., Ricker J.H., Diaz-Arrastia R., Merchant R.E., Temkin N.R., Melton S., Dikmen S.S. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT). JAMA 2012, 308:1993-2000.
284. Zanier E.R., Montinaro M., Vigano M., Villa P., Fumagalli S., Pischiutta F., Longhi L., Leoni M.L., Rebulla P., Stocchetti N., Lazzari L., De Simoni M.G. Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit. Care Med. 2011, 39:2501-2510.
285. Zhang N., Xing M., Wang Y., Tao H., Cheng Y. Repetitive transcranial magnetic stimulation enhances spatial learning and synaptic plasticity via the VEGF and BDNF-NMDAR pathways in a rat model of vascular dementia. Neuroscience 2015, 311:284-291.
286. Zhu Z.F., Wang Q.G., Han B.J., William C.P. Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Res. Bull. 2010, 83:272-277.